Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors
Open Access
- 1 November 1977
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 146 (5) , 1420-1435
- https://doi.org/10.1084/jem.146.5.1420
Abstract
A functional subpopulation of murine B [bone marrow-derived] lymphocytes proliferate in semisolid agar culture in the presence of 2-mercaptoethanol to form colonies. The effects of diffusible macrophage-derived factors on this focal proliferation was investigated using a 2-layer culture system which prevented macrophage-lymphocyte contact and permitted B-cell activation to be critically assessed under conditions of extremely low cell densities. Adherent peritoneal macrophages incorporated within underlayers of spleen or lymph node cell cultures potentiated the number and size of developing B-cell colonies. These effects were most striking when low numbers of spleen or lymph node cells or macrophage-depleted lymphoid cell suspensions were used. Macrophage-depleted lymph node cells gave rise to virtually no colonies, but colony-forming ability was restored by the presence of an optimal number of macrophages. When the number of macrophages exceeded that required for optimal stimulation, colony formation was suppressed; an effect which was largely prevented by indomethacin, an inhibitor of prostaglandin synthesis. Under these conditions, stimulation and inhibition of B-cell activation by macrophages could be dissociated, indicating that each signal is selectively controlled by individual molecules elaborated by the macrophage. With an appropriate number of macrophages required for B-cell activation and sufficient, indomethacin to inhibit the accumulation of macrophage-derived prostaglandin, B-lymphocyte clonal proliferation was a linear function of the number of B cells placed in culture. In the absence of macrophages, B-cell colony formation was potentiated by [Salmonella typhosa] lipopolysaccharide [LPS] and intact sheep erythrocytes through a mechanism different from that of the macrophage-derived stimulatory factor. LPS and sheep erythrocytes were also capable of modulating the production and/or release of B-cell stimulatory and inhibitory factors by the macrophage. Parallel studies of conventional mitogen-stimulated lymphocyte cultures did not show a requirement for macrophages and confirm that the semisolid assay is uniquely suited to studies on the regulatory role of the macrophage in B-cell activation.This publication has 35 references indexed in Scilit:
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hemopoietic cell factorsCellular Immunology, 1977
- Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice.The Journal of Experimental Medicine, 1977
- Regulation of Clonal B-lymphocyte Proliferation by Anti-immunoglobulin or Anti-Ia AntibodiesCold Spring Harbor Symposia on Quantitative Biology, 1977
- The Induction and Regulation of Guinea Pig B-Lymphocyte Proliferation in VitroThe Journal of Immunology, 1976
- MECHANISM OF ACTIVATION OF THE BONE MARROW-DERIVED LYMPHOCYTEThe Journal of Experimental Medicine, 1973
- Production by Stimulated Macrophages of Factors depressing Lymphocyte TransformationNature, 1973
- Indomethacin and Aspirin abolish Prostaglandin Release from the SpleenNature New Biology, 1971
- Inhibition of Spleen Cell DNA Synthesis by Autologous MacrophagesThe Journal of Immunology, 1966
- The Suppressive Role of Mouse Peritoneal Phagocytes in Agglutinin ResponseThe Journal of Immunology, 1965